India's drug tests

T. V. Padma

首页> 外文期刊>Nature >India's drug tests

【24h】

India's drug tests

机译：印度的药物测试

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The average cost of a clinical trial in the United States is US$180 million. The average cost in India is US$100 million. No surprise, then, that multinational companies are flocking to India to launch their trials. "It's a lot cheaper to do things in India," says Sameer Deb, general manager of government affairs at Glaxo-SmithKline' s office in Mumbai. Multinational companies are not the only ones to benefit financially from these studies — India does too. The consultancy firm McKinsey estimates that US and European pharmaceutical companies will spend US$1.5 billion per year on clinical trials in India by 2010.

机译：在美国，临床试验的平均费用为1.8亿美元。印度的平均成本为1亿美元。因此，毫不奇怪的是，跨国公司涌向印度进行审判。葛兰素史克（Glaxo-SmithKline）孟买办事处政府事务总经理Sameer Deb表示：“在印度做事要便宜得多。”跨国公司并不是唯一从这些研究中获利的公司-印度也是如此。咨询公司麦肯锡估计，到2010年，美国和欧洲的制药公司每年将在印度的临床试验上花费15亿美元。

著录项

来源
《Nature》 |2005年第7050期|p.485|共1页
作者
T. V. Padma;
展开▼
作者单位

展开▼
收录信息美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
原文格式 PDF
正文语种 eng
中图分类自然科学总论;
关键词

相似文献

外文文献
中文文献
专利

1. Threefold Increase in the Number of Drug Resistant TB Cases after Introduction of Universal Drug Susceptibility Testing: Experiences from Two South India Districts [J] . Sanath Kumar Gurram Krishnamurthy, Sharath Burugina Nagaraja, Tanu Anand, Journal of Tuberculosis Research . 2020,第2期

机译：三重增加耐药结核病患者在引入普遍的药物易感性测试之后：两个南印度地区的经验
2. European drug regulator recommends suspending 300 drugs tested by Indian CRO firm [J] . Chemical Weekly group Chemical Weekly . 2017,第35期

机译：欧洲药物监管机构建议暂停印度CRO公司测试300种药物
3. A Comparative Study of Drug Susceptibility Testing Techniques for Identification of Drug Resistant TB in a Tertiary Care Centre, South India [J] . J. Anto Jesuraj Uday Kumar, Hiresave Srinivasa, Justy Antony Chiramal Journal of Tuberculosis Research . 2017,第1期

机译：南印度高等护理中心鉴定耐药结核病药物易感性试验技术的比较研究
4. Position of Gateway Drugs in the Spectrum of Adolescent Drug-Use Initiation in Indiana: Relevance of Market Basket Analysis of Data Mining in Detection of Common Substance-Use Initiation Sequences [C] . Ahmed H. Youssef Agha, Wasantha P. Jayawardene International Conference on Data Mining . 2011

机译：印第安纳青少年药物用途谱谱中的网关药物的位置：数据挖掘在常用物质起始序列检测中的市场篮子分析的相关性
5. Would not-for-cause randomized drug testing reduce the incidence of drug misuse among certified registered nurse anesthetists? [D] . Gavin, Katy Gayle 2015

机译：是否会因为原因而进行随机药物测试，以减少注册的注册护士麻醉师滥用药物的发生率？
6. The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis [O] . Kuldeep Singh Sachdeva, Neeraj Raizada, Radhey Shyam Gupta, -1

机译：预先进行药敏试验对印度耐多药结核病流行的潜在影响
7. Threefold Increase in the Number of Drug Resistant TB Cases after Introduction of Universal Drug Susceptibility Testing: Experiences from Two South India Districts [O] . Sanath Kumar Gurram Krishnamurthy, Sharath Burugina Nagaraja, Tanu Anand, 2020

机译：三重增加耐药结核病患者在引入普遍的药物易感性测试之后：两个南印度地区的经验

India's drug tests

摘要

著录项

相似文献

相关主题

期刊订阅